EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project

Anaëlle Monfort iD, Evelina Cardoso, Chin B Eap iD, Nicolas Ansermot, Severine Crettol iD, Céline J Fischer Fumeaux, Myriam Bickle Graz, Mathilde Morisod Harari, Etienne Weisskopf, Peggy Gandia iD, Karel Allegaert, Pieter Annaert iD und 10 weitere

British Journal of Clinical Pharmacology · 2024-11 · 90 (11) · 2849-2860

DOI: 10.1111/bcp.16177 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 19.07.2024. Verfasst von Anaëlle Monfort und 21 weiteren Autor:innen. Beteiligte Einrichtung: CHU Sainte-Justine, Montréal, QC, Canada. Hauptthemen laut MEDLINE: Sertraline, Milk, Human, Selective Serotonin Reuptake Inhibitors, Fetal Blood. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking, European Union's Horizon 2020, EFPIA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Sertraline is frequently prescribed for mental health conditions in both pregnant and breastfeeding women. According to the limited available data, only small amounts of sertraline are transferred into human milk, yet with a large amount of unexplained interindividual variability. This study aimed to develop a population pharmacokinetic (popPK) model to describe the pharmacokinetics of sertraline during the perinatal period and explain interindividual variability.

Methods

Pregnant women treated with sertraline were enrolled in the multicenter prospective cohort SSRI‐Breast Milk study. A popPK model for sertraline maternal plasma and breast milk concentrations was developed and allowed estimating the milk‐to‐plasma ratio (MPR). An additional fetal compartment allowed cord blood concentrations to be described. Several covariates were tested for significance. Ultimately, model‐based simulations allowed infant drug exposure through placenta and breast milk under various conditions to be predicted.

Results

Thirty‐eight women treated with sertraline were included in the study and provided 89 maternal plasma, 29 cord blood and 107 breast milk samples. Sertraline clearance was reduced by 42% in CYP2C19 poor metabolizers compared to other phenotypes. Doubling milk fat content increased the MPR by 95%. Simulations suggested a median daily infant dosage of 6.9 μg kg −1 after a 50 mg maternal daily dose, representing 0.95% of the weight‐adjusted maternal dose. Median cord blood concentrations could range from 3.29 to 33.23 ng mL −1 after maternal daily doses between 25 and 150 mg.

Conclusions

Infant exposure to sertraline, influenced by CYP2C19 phenotype and breast milk fat content, remains low, providing reassurance regarding the use of sertraline during pregnancy and breastfeeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SertralineMilk, HumanSelective Serotonin Reuptake InhibitorsFetal BloodModels, BiologicalBreast FeedingHumansFemalePregnancyAdultProspective StudiesInfant, NewbornYoung AdultPregnancy Complications

Stichwörter der Autor:innen

breastfeedinginfant exposurepopulation pharmacokinetic modellingpregnancysertraline

Substanzen

SertralineSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • CHU Sainte-Justine, Montréal, QC, Canada.
  • Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
  • Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
  • Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva and University of Lausanne, Lausanne and Geneva, Switzerland.

ORCID-Profile: Anaëlle Monfort, Chin B Eap, Severine Crettol, Peggy Gandia, Pieter Annaert, Alice Panchaud, Monia Guidi

Förderung

  • Innovative Medicines Initiative 2 Joint Undertaking
  • European Union's Horizon 2020
  • EFPIA
  • Swiss National Science Foundation
  • European Federation of Pharmaceutical Industries and Associations
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Monfort, A., Cardoso, E., Eap, C. B., Ansermot, N., Crettol, S., Fischer Fumeaux, C. J., Graz, M. B., Harari, M. M., Weisskopf, E., Gandia, P., Allegaert, K., Annaert, P., Nordeng, H., Hascoët, J. M., Claris, O., Epiney, M., Ferreira, E., Leclair, G., Csajka, C., …, & collaborators of the SSRI Breast Milk study (2024). A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project. British Journal of Clinical Pharmacology, 90(11), 2849-2860. https://doi.org/10.1111/bcp.16177

Vancouver

Monfort A, Cardoso E, Eap CB, Ansermot N, Crettol S, Fischer Fumeaux CJ, et al. A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project. British Journal of Clinical Pharmacology. 2024;90(11):2849-2860. doi:10.1111/bcp.16177

BibTeX
@article{Monfort2024,
  author = {Monfort, Anaëlle and Cardoso, Evelina and Eap, Chin B and Ansermot, Nicolas and Crettol, Severine and Fischer Fumeaux, Céline J and Graz, Myriam Bickle and Harari, Mathilde Morisod and Weisskopf, Etienne and Gandia, Peggy and Allegaert, Karel and Annaert, Pieter and Nordeng, Hedvig and Hascoët, Jean-Michel and Claris, Olivier and Epiney, Manuella and Ferreira, Ema and Leclair, Grégoire and Csajka, Chantal and Panchaud, Alice and Guidi, Monia and collaborators of the SSRI Breast Milk study, collaborators of the SSRI Breast Milk study},
  title = {A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  volume = {90},
  number = {11},
  pages = {2849--2860},
  doi = {10.1111/bcp.16177}
}
Kostenlos starten →